SilcsBio
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1100 Wicomico St Ste 323, Baltimore, Mar...Phone Number
(410) 401-9907Website
www.silcsbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SilcsBio
SilcsBio specializes in computer-aided drug design (CADD) through its innovative software solutions, including SILCS, SILCS-Biologics, and CGenFF. The company offers consultation and training services to enhance drug discovery processes, enabling teams to accelerate timelines and reduce costs. Their proprietary technology generates detailed 3D free energy maps, facilitating the identification of potential drug targets. SilcsBio aims to support pharmaceutical and biotechnology companies in optimizing their drug development pipelines.Explore more
SilcsBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SilcsBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
SilcsBio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if SilcsBio had a recent Job posting/layoffs
Earning: See what the market has to say on SilcsBio recently announced quarterly report
Check out if SilcsBio is spiking on competitors!
Check if SilcsBio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when SilcsBio launches new products
Funding: Get notified immidiatlly once SilcsBio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at SilcsBio
Recommended Actions
Find VP level buyers at SilcsBio
Find 3 more new buyers
Compare Similar Companies to SilcsBio
Compare insights from companies similar to SilcsBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SilcsBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SilcsBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SilcsBio.
SilcsBio financials insights
Gather financial insights about SilcsBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Other Financing Round
$1.3M
SilcsBio Tech Stack
A closer look at the technologies used by SilcsBio
SilcsBio News & Media
Rasio Raises $1.5 Million to Advance Drug Development - Early Charm Ventures
New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research December 2, 2021, Baltimore, MD – Rasio Therapeutics a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop new drugs for oncology, today announced it has received $1.5 million in new financing. This investment, led by Bluedot Bio LLC, will enable Rasio to advance promising leads and develop ongoing partnerships for drugDelaware Innovation Space Makes $265,000 in First Fund Investments
WILMINGTON, Del.--(BUSINESS WIRE)-- #biotech--Delaware Innovation Space, a multi-dimensional, non-profit incubator and accelerator for science-based start-up companies, announced today that it has invested a total of $265,000 in three companies, including Gaskiya Diagnostics, Layer Metrics and Revolve Biotechnologies. All three companies will join the Delaware Innovation Space as new resident companies in addition to receiving capital investments. Each company was selected from a pool of over 50GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound
PALO ALTO, Calif. and BALTIMORE, Dec. 3, 2019 /PRNewswire/ -- GEn1E Lifesciences Inc., a Y Combinator-backed biotech startup focused on curing inflammatory and age-related diseases, announced today that it has acquired an exclusive, worldwide and all-fields license to the University of...GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound
GEn1E Lifesciences Inc., a Y Combinator-backed biotech startup focused on curing inflammatory and age-related diseases, announced today that it has acquired an exclusive, worldwide and all-fields license to the University of Maryland, Baltimore's (UMB) specific and function selective p38a kinase inhibitor program.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SilcsBio
Sign Up For FreeTo access detailed company insights
SilcsBio specializes in computer-aided drug design (CADD) through its innovative software solutions, including SILCS, SILCS-Biologics, and CGenFF. The company offers consultation and training services to enhance drug discovery processes, enabling teams to accelerate timelines and reduce costs. Their proprietary technology generates detailed 3D free... Read More
